Paroxetine Hydrochloride Controlled Release 25 mg Tablets
The RUPATINE CR-25 tablet is an antidepressant that is orally administered as a controlled-release tablet containing 25 mg of Paroxetine Hydrochloride. It is manufactured by the company named Eridanus Healthcare. The CR tablets are designed in such a way that Paroxetine can be absorbed slowly over time into the body, hence achieving more stable levels of plasma drug concentration and decreasing side effects associated with high peak concentrations and better patient tolerance than the immediate-release form of Paroxetine. Paroxetine is one of the potent selective serotonin reuptake inhibitors (SSRIs), and it is one of the most prescribed antidepressants in psychiatry and Neuro/Psychiatry outpatient clinics.
RUPATINE CR-25 is available through the company's specialised Neuro/Psychiatry PCD Pharma Franchise and is supplied in the high-quality 10×10 Alu-Alu blister package.
Uses and Indications of Paroxetine Hydrochloride Controlled Release 25 mg Tablets
Rupatine CR-25 is an option in the treatment of multiple mental illnesses. Below are some of the uses of Rupatine CR-25.
RUPATINE CR-25 is used by psychiatrists and doctors to treat the following conditions:
- Major Depressive Disorder (MDD): persistently depressed mood, anhedonia, and lack of interest
- Generalised Anxiety Disorder (GAD): ongoing and extreme worry and anxiety
- Social Anxiety Disorder (SAD): extreme fear and embarrassment in social settings
- Panic Disorder: repeated panic attacks without warning and anticipatory anxiety
- Obsessive-Compulsive Disorder (OCD): obsessive thoughts and compulsive behaviour
- Post-Traumatic Stress Disorder (PTSD): flashbacks and nightmares after a traumatic event
- Premenstrual Dysphoric Disorder (PMDD): depression associated with the luteal phase of menstrual periods
How do Paroxetine Hydrochloride Controlled Release 25 mg Tablets Work?
Paroxetine is a highly potent and selective serotonin reuptake inhibitor (SSRI). It functions by binding to the SERT protein on presynaptic neurons to inhibit the reuptake of serotonin from the synaptic cleft back to the presynaptic neuron. As a result, there is an increase in the levels of serotonin at the synaptic cleft, resulting in antidepressant and anxiolytic effects. Paroxetine has mild anticholinergic and noradrenergic actions. The controlled-release form slows and prolongs the absorption of the drug, hence lowering the peak plasma level and minimising the risk of nausea, the common adverse effect associated with SSRIs.
Dosage and Administration
Usage of RUPATINE CR-25 is strictly limited to oral administration only. The whole tablet needs to be taken intact; it must not be crushed, chewed, or broken since this would affect its controlled-release property. It is taken once every day during the morning meal with or without food at the discretion of the prescribing psychiatrist/physician. Its usage should be done according to the dose and frequency instructed by the prescribing physician. Its abrupt discontinuation must never be attempted to prevent withdrawal symptoms.
PCD Pharma Franchise for RUPATINE CR-25 – Eridanus Healthcare
Eridanus Healthcare is a specialised Neuro/Psychiatry pharmaceutical company dealing in an exclusive range of prescription medicines belonging to Anti-Depressants, Anti-Anxiety, CNS & Neurological Disorders, Psychiatry, Neurological Pain, and allied therapeutic categories. Pharma professionals, medical representatives, and distributors from all over India are cordially invited to work with us for the PCD Pharma Franchise and Monopoly distribution rights of RUPATINE CR-25 and our entire Neuro/Psychiatry product range.
Why should you choose Eridanus Healthcare for Neuro PCD Pharma Franchise?
- Monopoly-based PCD Pharma Franchise rights for Paroxetine Hydrochloride Controlled Release 25 mg Tablets
- Specialised product portfolio – Anti-Depressants, Anti-Anxiety, Anti-Psychotics, CNS drugs, Neurological Pain, and Nutrition & Wellness products
- Profitable net rates and attractive margins with MRP-based pricing
- GMP-certified manufacture under WHO guidelines guaranteeing quality
- Free marketing material such as visual aids, MR bag, sample kits, reminder card, and product literature
- Prompt order processing and dependable logistics across India with punctual delivery
- Franchise support team to help you manage business and train you in product knowledge
- Growing market for Neuro/Psychiatry with increasing awareness and prescriptions in India
Disclaimer: RUPATINE CR-25 is a Schedule H / prescription-only medicine. Use strictly under the supervision of a qualified psychiatrist or registered medical practitioner. This document is for informational and PCD Pharma Franchise marketing purposes only and does not constitute medical advice.